Aemetis (AMTX) Competitors $1.96 +0.08 (+4.26%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$1.99 +0.03 (+1.53%) As of 08:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AMTX vs. LXFR, ASPI, SLI, ARQ, TSE, ADUR, VGAS, ORGN, ALTO, and LNZAShould you be buying Aemetis stock or one of its competitors? The main competitors of Aemetis include Luxfer (LXFR), ASP Isotopes (ASPI), Standard Lithium (SLI), ARQ (ARQ), Trinseo (TSE), Aduro Clean Technologies (ADUR), Verde Clean Fuels (VGAS), Origin Materials (ORGN), Alto Ingredients (ALTO), and LanzaTech Global (LNZA). These companies are all part of the "chemicals" industry. Aemetis vs. Luxfer ASP Isotopes Standard Lithium ARQ Trinseo Aduro Clean Technologies Verde Clean Fuels Origin Materials Alto Ingredients LanzaTech Global Aemetis (NASDAQ:AMTX) and Luxfer (NYSE:LXFR) are both small-cap energy companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, media sentiment, valuation, community ranking, dividends and analyst recommendations. Does the MarketBeat Community favor AMTX or LXFR? Luxfer received 110 more outperform votes than Aemetis when rated by MarketBeat users. Likewise, 66.59% of users gave Luxfer an outperform vote while only 59.74% of users gave Aemetis an outperform vote. CompanyUnderperformOutperformAemetisOutperform Votes18159.74% Underperform Votes12240.26% LuxferOutperform Votes29166.59% Underperform Votes14633.41% Do institutionals and insiders believe in AMTX or LXFR? 27.0% of Aemetis shares are held by institutional investors. Comparatively, 90.8% of Luxfer shares are held by institutional investors. 15.9% of Aemetis shares are held by insiders. Comparatively, 1.2% of Luxfer shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is AMTX or LXFR more profitable? Luxfer has a net margin of 2.37% compared to Aemetis' net margin of -33.21%. Luxfer's return on equity of 9.26% beat Aemetis' return on equity.Company Net Margins Return on Equity Return on Assets Aemetis-33.21% N/A -40.11% Luxfer 2.37%9.26%5.13% Do analysts prefer AMTX or LXFR? Aemetis currently has a consensus target price of $14.56, indicating a potential upside of 642.98%. Given Aemetis' stronger consensus rating and higher probable upside, equities analysts clearly believe Aemetis is more favorable than Luxfer.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aemetis 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75Luxfer 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media favor AMTX or LXFR? In the previous week, Aemetis had 1 more articles in the media than Luxfer. MarketBeat recorded 3 mentions for Aemetis and 2 mentions for Luxfer. Aemetis' average media sentiment score of 1.40 beat Luxfer's score of 1.33 indicating that Aemetis is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aemetis 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Luxfer 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, AMTX or LXFR? Aemetis has a beta of 1.48, meaning that its stock price is 48% more volatile than the S&P 500. Comparatively, Luxfer has a beta of 0.93, meaning that its stock price is 7% less volatile than the S&P 500. Which has preferable earnings and valuation, AMTX or LXFR? Luxfer has higher revenue and earnings than Aemetis. Aemetis is trading at a lower price-to-earnings ratio than Luxfer, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAemetis$267.64M0.39-$46.42M-$1.98-0.99Luxfer$391.90M0.81-$1.90M$0.6817.40 SummaryLuxfer beats Aemetis on 11 of the 18 factors compared between the two stocks. Remove Ads Get Aemetis News Delivered to You Automatically Sign up to receive the latest news and ratings for AMTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AMTX vs. The Competition Export to ExcelMetricAemetisIndustrial organic chemicals IndustryEnergy SectorNASDAQ ExchangeMarket Cap$104.51M$2.37B$7.73B$8.06BDividend YieldN/A3.77%10.65%4.01%P/E Ratio-0.8716.4947.4219.03Price / Sales0.399.2921,017.6893.17Price / CashN/A23.6235.2834.64Price / Book-0.361.413.694.33Net Income-$46.42M-$13.51M$4.27B$247.06M7 Day Performance-2.49%-1.37%0.73%-0.37%1 Month Performance8.89%-7.56%0.88%-3.85%1 Year Performance-67.28%-29.05%168.97%1.27% Aemetis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AMTXAemetis1.5782 of 5 stars$1.96+4.3%$14.56+643.0%-67.4%$104.51M$267.64M-0.87160LXFRLuxfer2.3716 of 5 stars$12.12flatN/A+12.8%$324.11M$391.90M36.731,400Positive NewsASPIASP Isotopes0.651 of 5 stars$4.27+0.9%$4.50+5.4%+10.0%$304.84M$3.38M-7.0076News CoverageGap UpSLIStandard Lithium2.4996 of 5 stars$1.40-3.4%$3.95+182.1%N/A$241.85MN/A2.37N/AARQARQ2.9848 of 5 stars$4.80-3.4%$9.50+97.9%-34.2%$201.67M$108.96M-480.00140TSETrinseo1.6734 of 5 stars$4.43+3.6%N/A+12.6%$157.00M$3.51B-0.453,400Short Interest ↓ADURAduro Clean TechnologiesN/A$5.28+2.7%$50.00+847.0%N/A$150.15M$299,021.000.00N/APositive NewsVGASVerde Clean Fuels0.1656 of 5 stars$3.93flatN/A-10.6%$125.96MN/A-7.862Positive NewsORGNOrigin Materials1.5584 of 5 stars$0.81-0.8%$1.50+85.6%+41.9%$118.19M$35.12M-1.42160Positive NewsGap DownALTOAlto Ingredients2.9656 of 5 stars$1.37+3.8%$5.50+301.5%-38.2%$105.01M$965.26M-2.63420LNZALanzaTech Global1.8733 of 5 stars$0.49-10.2%$4.00+723.6%-90.8%$96.05M$58.03M-0.753Positive NewsGap DownHigh Trading Volume Remove Ads Related Companies and Tools Related Companies LXFR Competitors ASPI Competitors SLI Competitors ARQ Competitors TSE Competitors ADUR Competitors VGAS Competitors ORGN Competitors ALTO Competitors LNZA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AMTX) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aemetis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aemetis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AMTX Stock Free AMTX Stock Alerts